Login / Signup

Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study.

Federica MagnèMaria CellerinoElisa BallettoKenda AluanMatilde IngleseMalgorzata MikulskaMatteo Bassetti
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Keyphrases
  • sars cov
  • multiple sclerosis
  • respiratory syndrome coronavirus
  • coronavirus disease
  • replacement therapy